Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: PrEP4U: Assessing the Effectiveness of Integrated Same-Day Lenacapavir Initiation and Follow-up Choice on PrEP Persistence [NA]

View source ↗

Summary

A clinical trial evaluating same-day initiation of lenacapavir for HIV pre-exposure prophylaxis and follow-up options to improve PrEP persistence. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenacapavir (lenacapavir)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV Pre-exposure Prophylaxis Use | NA | Status: NOT_YET_RECRUITING